Cullinan Therapeutics, Inc. (CGEM)
21.78
-0.29
(-1.31%)
USD |
NASDAQ |
Sep 01, 16:00
21.78
0.00 (0.00%)
After-Hours: 16:13
Cullinan Therapeutics Cash from Operations (TTM) : -159.25M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -159.25M |
| March 31, 2026 | -178.64M |
| December 31, 2025 | -175.75M |
| September 30, 2025 | -174.27M |
| June 30, 2025 | -171.53M |
| March 31, 2025 | -150.21M |
| December 31, 2024 | -145.30M |
| September 30, 2024 | -126.81M |
| June 30, 2024 | -126.81M |
| March 31, 2024 | -121.52M |
| December 31, 2023 | -134.28M |
| September 30, 2023 | -141.13M |
| Date | Value |
|---|---|
| June 30, 2023 | -161.34M |
| March 31, 2023 | -155.75M |
| December 31, 2022 | -126.66M |
| September 30, 2022 | -116.85M |
| June 30, 2022 | -73.05M |
| March 31, 2022 | -63.83M |
| December 31, 2021 | -43.43M |
| September 30, 2021 | -37.70M |
| June 30, 2021 | -36.22M |
| March 31, 2021 | -26.27M |
| December 31, 2020 | -29.77M |
| September 30, 2020 | -25.20M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Rallybio Corp. | 26.71M |
| MapLight Therapeutics, Inc. | -174.67M |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |
| Sangamo Therapeutics, Inc. | -90.34M |